Addiction
On the cutting edge of research
ADDICTION, SUBSTANCE ABUSE & DETOX RESEARCH STUDIES
Segal Trial is South Florida’s clinical research facility for substance use disorders. A private research facility offering multiple addiction, substance abuse and detox clinical studies at our full-service facilities. Using state-of-the-art equipment, board certified doctors and staff who are passionate about patient care and recovery.
MILESTONES THAT DEFINE US
Since our 2003 inception, Segal Trials has made significant strides in addiction research. With over 76 successful Phase I-IV inpatient and outpatient studies, we have contributed to advancing knowledge and treatment options for addiction. Our expertise extends to various substances, including alcohol, opioids, cocaine, tobacco, and cannabis. Backed by our board-certified psychiatrists, who actively contribute to protocol writing, we maintain a strong presence in advocacy groups and collaborate closely with local addiction centers.
- 76 Phase I-IV inpatient & outpatient addiction research studies
Exploring Substance Research
At Segal Trials, we offer addiction, substance abuse, and detox research studies targeting specific indications. If you or someone you know is interested in participating, reach out to us for more information.
Types of Addiction Studies
This study evaluates the safety, effectiveness, and tolerability of two different dosages of the opioid use disorder (OUD) medication, SUBLOCADE® (extended-release buprenorphine). SUBLOCADE is currently approved to suppress withdrawal signs and symptoms in patients who have opioid use disorder.
This study provides information about the best maintenance dosage of SUBLOCADE for those who are seeking treatment for opioid use disorder and have high-risk opioid use and designed for those who struggle with dependency on prescription and non-prescription opioid drugs, such as:
- Codeine
- Morphine
- Oxycodone
- Hydrocodone
- Heroin
- Fentanyl
This study is a single-dose, for participants with moderate or severe Opioid Use disorder (OUD). This study is to find the best maintenance dosage of SUBLOCADE for those who are seeking treatment for opioid use disorder and have high-risk opioid use. Designed for those who struggle with dependency on prescription and non-prescription opioid drugs, such as:
- Codeine
- Morphine
- Oxycodone
- Hydrocodone
- Heroin
- Fentanyl
No matter how cocaine is taken, it is dangerous. Some of the most common serious problems include
- Heart problems, including heart attacks
- Respiratory effects, including respiratory failure
- Nervous system problems, including strokes
- Digestive problems
This study is for participants who want to decrease their use or intake of Cannabis. The study evaluates in treatment-seeking patients with cannabis use disorder to assess the efficacy, safety, and tolerability of an investigational drug to reducing cannabis use.
This clinical study evaluates the safety and efficacy of an investigation medication for patients who are moderate-to-severe cocaine users.
Stay tuned for our upcoming studies targeting Alcohol Use Disorder, Cannabis Withdrawal, and Tobacco Use Disorder. We are continually expanding our research efforts to address a wide range of addiction-related challenges.
MEET THE EXPERTS: Addiction, Substance Abuse & Detox Clinical Team
Meet Our Experts Our Addiction, Substance Abuse & Detox division comprises highly trained facilitators supported by a team of dedicated research professionals and innovative recruitment experts. Meet the experts who lead the way in our field: Dr. Kakar, Dr. LaPeyra, and Dr. Adams.
Dr. Rishi Kakar
Chief Scientific Officer • Medical Director and Principal Investigator • Board Certified Psychiatrist • Diplomate, American Board of Psychiatry and Neurology
Dr. Olga Marie Lapeyra
Board-Eligible in Adult Psychiatry
